4.4.8 Adverse event reporting

Adverse Event Reporting

Adverse event reporting is an important aspect of prescribing in the UK, as it helps to monitor the safety and effectiveness of medications in routine use. In the UK, adverse event reporting is governed by the Yellow Card Scheme, which is run by the Medicines and Healthcare products Regulatory Agency (MHRA).

The Yellow Card Scheme allows healthcare professionals and patients to report suspected adverse reactions to medications, medical devices, and vaccines. Reports can be submitted online or by completing a paper form. The information collected through the Yellow Card Scheme is used to identify trends and patterns in adverse events, and to inform decisions about the safety and efficacy of these products.

In the UK, healthcare professionals are encouraged to report suspected adverse events to the Yellow Card Scheme. This helps to ensure that the latest information about the safety and efficacy of medications is available to healthcare professionals and the general public, and can inform decisions about the use of these products in the future (MHRA, 2021)

References:

(1) Medicines and Healthcare products Regulatory Agency (MHRA). (2021). Yellow Card Scheme. https://yellowcard.mhra.gov.uk/

(2) Medicines and Healthcare products Regulatory Agency(MHRA). (2015). The Yellow Card Scheme: guidance for healthcare professionals, patients and the public. [online] GOV.UK. Available at: https://www.gov.uk/guidance/the-yellow-card-scheme-guidance-for-healthcare-professionals.